High androgen levels during pregnancy increase the risk of PCOS for several generations

Daughters of women with polycystic ovarian syndrome (PCOS) are five times more likely to be diagnosed with PCOS as adults, and the generational transmission is driven by high androgen levels during pregnancy, researchers at Karolinska Institutet in Sweden report. Their results, which are based on register-based and clinical studies as well as transgenerational animal studies, are published in Nature Medicine.

PCOS affects more than ten percent of women of fertile age and is characterised by high levels of androgens (male sex hormones), ovulation disorders and difficulties conceiving. The syndrome is also associated with mental health conditions and a greatly increased risk of type 2 diabetes and obesity, which aggravate the symptoms. While the causes of PCOS are not fully known, the uterine environment plays a key role.

In this study, researchers at Karolinska Institute combined human and mouse studies to ascertain how and to what extent the syndrome is passed down to coming generations. A registry-based study and a case-control study show that daughters of women with PCOS are five times more likely to develop the syndrome in adulthood; they have higher levels of androgens and irregular menstrual cycles as well as abdominal obesity, higher BMI and higher blood pressure.

In the animal studies, pregnant mice were fed an obesogenic diet and exposed to high levels of androgens mimicking those conditions observed in pregnant women with PCOS. Their offspring were then fed with a regular diet and monitored into adulthood, at which point the females’ reproductive and metabolic profiles were examined. To find out if PCOS-like symptoms are transmitted to coming generations, four groups of these mice were mated to study the reproductive and metabolic profile in second-generation offspring. The whole process was then repeated for a third generation to address whether a PCOS phenotype could be transmitted across several generations.

“By doing this we were able to demonstrate that the combination of high androgen levels during pregnancy and an obesogenic diet consumed by the grandmothers has a deleterious effect on the fetal development of the second generation, leading to intrauterine growth restriction and miscarriage partly due to placenta dysfunction, which is in line with previous observations of women with PCOS,” says Professor Elisabet Stener-Victorin at the Department of Physiology and Pharmacology, Karolinska Institutet, who co-led the study with associate professor and departmental colleague Qiaolin Deng.

The results show that the main contributor to the generational transmission of PCOS symptoms are androgens.

­“This is a formerly unknown biological mechanism that trigger us to explore in more detail how germ cells are programmed by androgens to cause daughters of women with PCOS developing reproductive and metabolic disorders as adults,” says Qiaolin Deng.

Analyses of the mice oocytes revealed alterations in gene expression that are involved in the cellular stress response, type 2 diabetes and DNA stability, changes that are passed down to future generations. Some of these genes could also be identified in serum from daughters of women with PCOS, which the researchers say could provide potential biomarkers for predicting an increased risk of syndrome transmission.

The study was financed by the Swedish Research Council, the Strategic Programme in Diabetes at Karolinska Institutet, the Novo Nordisk Foundation, the Adlerbert Research Foundation, the Swedish Society for Medical Research (SSMF), the Åke Wiberg Foundation, Region Stockholm (ALF funding), the Royal Swedish Academy of Sciences and the Chilean National Fund for Scientific and Technological Development (FONDECYT). Co-author Henrik Larsson has received speaker fees from Evolan Pharma and Shire and research grants from Shire, although none associated with the present study. No other author has reported any potential conflict of interest.

Publication: “Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome”. Sanjiv Risal, Yu Pei, Haojiang Lu, Maria Manti, Romina Fornes, Han-Pin Pui, Zhiyi Zhao, Julie Massart, Claes Ohlsson, Eva Lindgren, Nicolas Crisosto, Manuel Maliqueo, Barbara Echiburú, Amanda Ladrón de Guevara, Teresa Sir-Petermann, Henrik Larsson, Mina A. Rosenqvist, Carolyn E. Cesta, Anna Benrick, Qiaolin Deng, Elisabet Stener-Victorin. Nature Medicine, online 2 December 2019, doi: 10.1038/s41591-019-0666-1.

For more information, please contact:
Elisabet Stener-Victorin, professor
Department of Physiology and Pharmacology, Karolinska Institutet
Tel: +46 70 564 3655
Email: elisabet.stener-victorin@ki.se
Website: http://ki.se/en/fyfa/reproductive-endocrinology-and-metabolism

Qiaolin Deng, associate professor
Department of Physiology and Pharmacology, Karolinska Institutet
Tel: +46 76 261 2920
Email: qiaolin.deng@ki.se
Website: https://staff.ki.se/people/qiaode

Karolinska Institutet is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.

Tags:

About Us

KAROLINSKA INSTITUTET PRESS OFFICE Opening hours: Monday–Friday 8–20 CET, weekends 9–17 CET Karolinska Institutet – a medical university ki.se

Subscribe

Media

Media